SuperworthJasper Therapeutics market cap JSPR
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $17M
- Highest close in our data
- $444.4M
- Apr 2024
Jasper Therapeutics is worth $17M at the close on Oct 23, 2026, at $0.51 a share.
That is down 56% over the last year and down 85% over five years.
Its highest close in our data was $444.4M in Apr 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $17M | $9.5M | $51.5M | −66% |
| 2025 | $49.3M | $28.9M | $289.1M | −85% |
| 2024 | $333.8M | $78.7M | $444.4M | +279% |
| 2023 | $88M | $54M | $218.8M | +380% |
| 2022 | $18.3M | $18.3M | $258.2M | −94% |
| 2021 | $297.1M | $99.5M | $372.9M | +137% |
| 2020 | $125.1M | $118.8M | $128.1M | n/a |
Against its peers
Companies in Healthcare nearest Jasper Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| JSPRJasper Therapeutics | $17M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Jasper Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.